Spitex-SpiTal-Autonomie-Reha-Kraft

NCT03154684 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2021-09-01

No results posted yet for this study

Summary

The primary purpose of this study is to test if the STARK comprehensive autonomy health care package improves lower extremity function over time at 6 weeks, 3, 6 and 12 months after hip or pelvis fracture compared to the standard of care.

Conditions

Interventions

OTHER

STARK intervention

The STARK Intervention is a new care concept for hip fracture patients that enable hip fracture patient to return to their home directly after discharge from acute care. The STARK comprehensive autonomy health care package includes following services; * Multidisciplinary collaboration of geriatricians, nurses and Spitex (ambulant nursing service at home) starting already during acute care * Inspection of the environment at the patient's home * Care and autonomy support * Social life support * Secondary prevention strategies: * Home exercise program (3x/weeks) * Protein enriched food preparation (20g whey protein/day) * Support to take vitamin D supplementation (2000 IU/day) * Recommendation and support to eat calcium rich foods * Motivation to be physically active

OTHER

Standard of Care

Standard of Care involves inpatient rehabilitation or home-based or inpatient transitional nursing care

Sponsors & Collaborators

  • Spitex Zürich, Switzerland

    collaborator UNKNOWN
  • City of Zurich, Switzerland

    collaborator UNKNOWN
  • University Hospital, Zürich

    collaborator OTHER
  • University of Applied Sciences of Western Switzerland

    collaborator OTHER
  • Ebnet Stiftung, Switzerland

    collaborator UNKNOWN
  • University of Zurich

    lead OTHER

Principal Investigators

  • Heike Bischoff-Ferrari, Prof. · Zentrum Alter und Mobilität

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-05
Primary Completion
2021-08-15
Completion
2021-08-15

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03154684 on ClinicalTrials.gov